We are live on ! Find out more
Temasek Holdings

Temasek Holdings Portfolio holdings

AUM $37.3B
1-Year Est. Return 12.6%
This Fund
S&P 500
This Quarter Est. Return
-2.09%
1 Year Est. Return
+12.6%
3 Year Est. Return
+93.72%
5 Year Est. Return
+64.47%
10 Year Est. Return
+501.94%
AUM
$12.8B
AUM Growth
+$109M
Cap. Flow
+$529M
Cap. Flow %
4.13%
Top 10 Hldgs %
89.64%
Holding
31
New
3
Increased
2
Reduced
1
Closed
2

Top Sells

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$42.4M
2
IQV icon
IQVIA
IQV
+$42.1M
3
MON
Monsanto Co
MON
+$31.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 35.35%
2 Industrials 26.93%
3 Healthcare 17.96%
4 Communication Services 5.57%
5 Materials 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
1
Alibaba
BABA
$296B
$4.3B 33.6%
54,076,397
+6,526,596
+14% +$511M
LVLT
2
DELISTED
Level 3 Communications Inc
LVLT
$3.35B 26.16%
65,031,667
GILD icon
3
Gilead Sciences
GILD
$181B
$1.15B 9.01%
13,830,516
INFO
4
DELISTED
IHS Markit Ltd. Common Shares
INFO
$690M 5.39%
21,173,310
TMO icon
5
Thermo Fisher Scientific
TMO
$230B
$428M 3.35%
2,899,315
UNVR
6
DELISTED
Univar Solutions Inc.
UNVR
$428M 3.35%
22,641,230
+4,546
+0% +$82.6K
EMC
7
DELISTED
EMC CORPORATION
EMC
$384M 3%
14,141,103
BMRN icon
8
BioMarin Pharmaceuticals
BMRN
$12.5B
$270M 2.11%
3,472,712
TRQ
9
DELISTED
Turquoise Hill Resources Ltd
TRQ
$247M 1.93%
7,321,388
VIRT icon
10
Virtu Financial
VIRT
$5.86B
$222M 1.73%
12,317,682
PYPL icon
11
PayPal
PYPL
$45.9B
$197M 1.54%
5,387,963
SYF icon
12
Synchrony
SYF
$25.4B
$166M 1.3%
6,561,333
PTLA
13
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$155M 1.21%
6,583,568
JD icon
14
JD.com
JD
$38.8B
$155M 1.21%
7,306,572
ALXN
15
DELISTED
Alexion Pharmaceuticals
ALXN
$143M 1.12%
1,226,630
VNET
16
VNET Group
VNET
$1.86B
$110M 0.86%
10,778,004
BEAV
17
DELISTED
B/E Aerospace Inc
BEAV
$98.2M 0.77%
+2,126,523
New +$102M
TOUR
18
Tuniu
TOUR
$54.1M
$69.1M 0.54%
819,444
REGN icon
19
Regeneron Pharmaceuticals
REGN
$81.8B
$44.1M 0.34%
126,351
ILMN icon
20
Illumina
ILMN
$32.6B
$38.9M 0.3%
285,024
JUNO
21
DELISTED
Juno Therapeutics, Inc.
JUNO
$35.2M 0.28%
915,750
AMRS
22
DELISTED
Amyris Inc.
AMRS
$31.4M 0.25%
4,639,481
EMWP
23
DELISTED
Eros Media World PLC
EMWP
$22.4M 0.17%
68,800
IBN icon
24
ICICI Bank
IBN
$107B
$18.3M 0.14%
+2,808,988
New +$18.1M
NTLA icon
25
Intellia Therapeutics
NTLA
$1.8B
$16.9M 0.13%
+790,527
New +$21M

Similar funds

Temasek Holdings's Q2 2016 Portfolio in Review

As of Q2 2016, Temasek Holdings held 31 positions worth $12.8B, up 0.86% from $12.7B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Temasek Holdings deployed $529M of net new capital in Q2 2016, opening 3 new positions and adding to 2 existing holdings. Its largest new stake was B/E Aerospace Inc: 2,126,523 shares worth $98.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, up from 32% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was IQVIA, an estimated $42.1M trimmed.

  • Temasek Holdings's largest Q2 2016 buy was B/E Aerospace Inc: 2,126,523 shares worth $98.2M.
  • Temasek Holdings added most to Alibaba in Q2 2016, an estimated $511M increase.
  • Temasek Holdings's biggest Q2 2016 reduction was IQVIA, cutting an estimated $42.1M.
  • Temasek Holdings fully exited Fidelity National Information Services in Q2 2016, selling an estimated $42.4M.
  • Temasek Holdings's ten largest holdings make up 90% of its $12.8B portfolio in Q2 2016.
  • Temasek Holdings opened 3 new positions and closed 2 in Q2 2016.
  • Temasek Holdings's portfolio value rose 0.86% quarter-over-quarter to $12.8B.

Based on Temasek Holdings's 13F filing for Q2 2016, filed 15 Aug 2016.